How many institutions held IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share in Q1 2021?

21 institutional investors reported IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share for Q1 2021. Use the holders table for investor-level position and value details.

Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD)

Q: What does CUSIP 67577R102 represent in this 13F holders report?

CUSIP 67577R102 is the security identifier for IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

CUSIP: 67577R102

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 71,813,353
Total 13F shares: 912,180
Share change: -1,314,332
Total reported value: $5,265,087
Price per share: $5.81
Number of holders: 21
Value change: -$7,635,114
Number of buys: 15
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 67577R102?
CUSIP 67577R102 identifies IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 67577R102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Altium Capital Management LLC	13F	Company	2.9%	2,068,530	$13,425,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.1%	73,820	$479,000	—	31 Dec 2020	13F
COMERICA BANK	13F	Company	0.04%	30,000	$322,000	—	31 Dec 2020	13F
Squarepoint Ops LLC	13F	Company	0.03%	19,572	$127,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	0.02%	14,268	$93,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	0%	2,207	$15,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0%	700	$5,000	—	31 Dec 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	413	$3,000	—	31 Dec 2020	13F
American Portfolios Advisors	13F	Company	0%	2	$13	—	31 Dec 2020	13F

Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q1 2021

As of 31 Mar 2021, Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 912,180 shares. The largest 10 holders included Altium Capital Management LP, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, NORRIS PERNE & FRENCH LLP/MI, PURA VIDA INVESTMENTS, LLC, COMERICA BANK, Regency Capital Management Inc.\DE, VANGUARD GROUP INC, BOOTHBAY FUND MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.